Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hope

Showing results (671-680 of 795) with videos related to

Pageof 80
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Can <sup>177</sup>Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter DataAzadeh Akhavanallaf, Zhonglin Lu, Avery B Peterson, et al.
Sedimentology|December 24, 2019
Integrating field and laboratory approaches for ripple development in mixed sand-clay-EPSJaco H Baas, Megan L Baker, Jonathan Malarkey, et al.
European Urology|November 9, 2024
Corrigendum to "Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)" [Eur Urol. 86(1) (2024) 52-60]Wesley R Armstrong, Amar U Kishan, Kiara M Booker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2021
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PETFrancesco Ceci, Daniela E Oprea-Lager, Louise Emmett, et al.
Oral Oncology|May 29, 2020
Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neckD Day, A Prawira, A Spreafico, et al.
Cell|June 17, 2006
A gene-centered C. elegans protein-DNA interaction networkBart Deplancke, Arnab Mukhopadhyay, Wanyuan Ao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2020
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide TherapyThomas A Hope, Lisa Bodei, Jennifer A Chan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
PSMA PET/CT-Derived Indicators and Outcomes After [<sup>177</sup>Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access ProgramKoichiro Kimura, Vishnu Murthy, Andrew F Voter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 30, 2023
PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective StudyMasatoshi Hotta, Andrei Gafita, Vishnu Murthy, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2014
Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynxH H Loong, E Winquist, J Waldron, et al.
Pageof 80

Showing results (671-680 of 795) with videos related to

Sort By:
Pageof 80
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 22, 2025
Can <sup>177</sup>Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter DataAzadeh Akhavanallaf, Zhonglin Lu, Avery B Peterson, et al.
Sedimentology|December 24, 2019
Integrating field and laboratory approaches for ripple development in mixed sand-clay-EPSJaco H Baas, Megan L Baker, Jonathan Malarkey, et al.
European Urology|November 9, 2024
Corrigendum to "Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774)" [Eur Urol. 86(1) (2024) 52-60]Wesley R Armstrong, Amar U Kishan, Kiara M Booker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2021
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PETFrancesco Ceci, Daniela E Oprea-Lager, Louise Emmett, et al.
Oral Oncology|May 29, 2020
Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neckD Day, A Prawira, A Spreafico, et al.
Cell|June 17, 2006
A gene-centered C. elegans protein-DNA interaction networkBart Deplancke, Arnab Mukhopadhyay, Wanyuan Ao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 5, 2020
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide TherapyThomas A Hope, Lisa Bodei, Jennifer A Chan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
PSMA PET/CT-Derived Indicators and Outcomes After [<sup>177</sup>Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access ProgramKoichiro Kimura, Vishnu Murthy, Andrew F Voter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 30, 2023
PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective StudyMasatoshi Hotta, Andrei Gafita, Vishnu Murthy, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2014
Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynxH H Loong, E Winquist, J Waldron, et al.
Pageof 80